Following on from in vitro experiments, which revealed that Ad-PUMA sensitizes the drug resistant glioma cells to TMZ treatment, it was further investigated whether this sensitization effect may also be detected in vivo in tumor xenograft animal models. This evidence concerns the gene BBC3 and glioma.